Patent · US Expired

Compositions of optically pure (+) norcisapride

US6242465A · kind A · utility

7Cited by
5References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 18, 2000
Grant dateJun 5, 2001
Priority date—
Expiry dateMay 18, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositons employing and methods utilizing the optically pure (+) isomer of norcisapride are disclosed. This compound has surprisingly been found to be a potent drug for the treatment of disorders of the central nervous system. The compound, (+) norcisapride, has also been found to be a potent antiemetic agent. Finally the (+) isomer of norcisapride also avoids certain adverse side effects and certain adverse drug interactions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.